a Part of BioTaiwan 2015 Events July 22-23, F, Bldg. A, CTBC Financial Park Organized by Taiwan Bio Industry Organization

Similar documents
Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations

Annual Meeting ISPE Japan Affiliate. Emerging Technology. - Age of Digital and Disruptive Innovation. Dates: 24th & 25th May, 2018

Organized by: Main Sponsors: Co-sponsors:

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

Asia Pacific Impact Investment workshop hosted by the Global Steering Group for Impact Investment (GSG), UNESCAP and the British Council

Tuesday, 6 November 2018

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Koen Dejonckheere. Professional experience. Board Memberships. Education

Asia Business Leaders Advisory Council (ABLAC) 2018 PROGRAM 2 March 2018 Omni King Edward Hotel Toronto, ON, Canada

MOSTI-APCTT Fourth Industrial Revolution Conference 2018

PECC-SINCPEC Conference on APEC ECONOMIES: A PARADIGM SHIFT? April 2012 Orchard Hotel, Singapore. DRAFT PROGRAMME as on 24 April, 2012

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

CASI Pharmaceuticals, Inc.

Crack the Code: Demystify the Success Factors for Career Development

The 21 st APEC Small and Medium Enterprises Ministerial Meeting Joint Ministerial Statement. Nanjing, China September 5, 2014

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

PROGRAM BIOPHARMACEUTICAL SECTOR

4:30-5:30 pm An Update on Chinese Domestic Politics: Implications for American Business

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

The Cannabis Industry Growth Opportunities for Professionals, Operators and Investors

THE СONCEPT OF THE MOSCOW INTERNATIONAL FORUM FOR INNOVATIVE DEVELOPMENT OPEN INNOVATIONS * October 31 November 2, * as of April

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

NEWS RELEASE. Life sciences companies tout their expertise in India

Asia Business Leaders Advisory Council (ABLAC) 2018 PROGRAM 2 March 2018 King Edward Hotel Toronto, ON, Canada

AGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine

WIRED BIOSCIENCE INSTITUTE. February 5-6, 2008 Winston Salem, North Carolina

TRANSLATIONAL SCIENCE

CONFERENCE. Osaka, December 13 to 15, 2017 PROGRAM. organized by the World Intellectual Property Organization (WIPO)

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

2nd Innovation & Entrepreneurship Forum

Biotech Concerto #6 Investment Process December 2008

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Health & Social Care Industrial Innovation

Medicines Manufacturing in the UK 2017

Jean W. Frydman Partner

European Patent Reform Forum USA December , New York

World Forum on Sport and Culture Meeting Overview

American Chamber of Commerce in Taipei

State of Licensing 2011 Update

Unleashing Social Entrepreneurship:

DAY ONE Thursday, 10 July 2014

CALIFORNIA-CHINA OFFICE OF TRADE AND INVESTMENT

Life Sciences Queensland announces latest LSQ Ambassadors

Innovation and the Changing Practice of Medicine

Biocommercialization: Providing Enabling Policy Environments

Intellectual Property, Technology Transfer and Commercialization

2015/SOM2/PPSTI/001 Agenda Item: 2. Draft Agenda. Purpose: Consideration Submitted by: Chair

Health 2.0 Asia 2016 Korea-China Program. Korea Program

AIF DISTINGUISHED SPEAKER SERIES 2015 CAN ASEAN RE-INVENT ITSELF?

Amount of Shares Held (Unit: Share) 90,804. Shareholder No. List No.

The Nation's Medical Countermeasure Stockpile: Opportunities to Improve the Sustainability of the CDC Strategic National Stockpile, A Workshop

Conflict of Interest and Medical Innovation: Ensuring Integrity while Facilitating Innovation in Medical Research A Workshop

ITRI Forum and Career Fair. 11:00 am to 7:30 pm, June 20, 2008 Santa Clara Convention Center, Santa Clara, California

ASIFMA Annual Conference 2014

Asia Regional Workshop. Strengthening Public-Private Partnerships. for. Sustainable Electricity and Energy Efficiency

2010/SCSC/WKSP1/001. Agenda. Submitted by: United States

[ Feature ] JAIC has the largest number of domestic and overseas entitles among the Japanese venture capital companies. Flexing the Muscles of

Then: Costs. Now: Processes. Next: Innovation.

Unleashing Social Entrepreneurship: New Partnerships for a Better World

CONFERENCE AGENDA. Empowering Your Clinical Trial Operations Through Digital Innovation. 5 6 December 2018, Grand Copthorne Waterfront, Singapore

8th Annual INSEAD Asian Private Equity and Venture Capital Conference

Mid-Atlantic - Eurasia Business Council (MAEBC/MARBC)

2018 International Conference of Korean Women in Finance

PROGRAM. Opening Remarks: Robert Thomson Editor-in-Chief, Dow Jones & Company Managing Editor, The Wall Street Journal

Patent Masters Symposium A part of the IPWatchdog Institute

Technology Transfer for Small and Medium Sized Enterprises

The Association s high-level visit to Hong Kong in April 2018

B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems

ASEM Seminar on Cooperation in Science, Technology & Innovation for Sustainable Development

A UN ENVIRONMENT WORLD BANK GROUP EVENT FINANCING FOR POLLUTION MANAGEMENT UN ENVIRONMENT ASSEMBLY

Will the Chinese Dragon Strengthen Your Business or Eat You Alive?

Inclusion Women at the Forefront of STEM

List of Directly Owned Subsidiaries Board of Directors and Supervisors

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016

Does your company know about IP rights and use them effectively to achieve business growth and protection?

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Mid-Atlantic - Russia Business Council (MARBC)

Conference Program. 6 th December School of Law Singapore Management University

ASEAN-Japan Seminar on FDI: Sharing Japanese SMEs' Dynamism in ASEAN's Integration May at Grand Prince Hotel Akasaka

Avoiding the Hidden Cliff: Succession Planning for Sustainability and Success

Workshop on. Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review?

FDA Centers of Excellence in Regulatory and Information Sciences

KISTEP-ISTIC. S&T Innovation Training Program for High Level Policy Makers SEPTEMBER 2016 KUALA LUMPUR, MALAYSIA

Funding New Innovations

REGISTRATION FORM:- 1. Title Dr/Mr./Ms. 2. First Name. 3. Last Name. 4. Designation. 5. Organization/Hospital/Institute. 6.

Exploring Opportunities in Renewable Energy

The Product Journey. An insight into Design, Sterilisation, Testing, Clinical Trial and Accreditation

Berlin Summit, Hotel Adlon Kempinski, April 26-27, 2012

GS Taipei Workshop 2018 Shaping the Future of an Inclusive Digital Society March 28, 2018 Venue: Ambassador Hotel Taipei

University of Technology, Sydney CI Labs, Series July 2012

HIGH LEVEL FORUM EXECUTIVE COMMITTEE

China Today: New Dimensions; New Opportunities Forum

8:45-9:45 am Chinese Domestic Politics: The New Peking Order. Michael Forsythe, Reporter, New York Times

ASEAN Open Innovation and Entrepreneurship Forum. Ministers of Science and Technology and Senior Officials from ASEAN member countries and

Global Economy & Capital Markets Forum 2018

Dammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe

with the support of the Government of Japan

Transcription:

a Part of BioTaiwan 2015 Events July 22-23, 2015 3F, Bldg. A, CTBC Financial Park www.bio-taiwan.com Organized by Taiwan Bio Industry Organization

BioBusiness Asia Conference 2015 Day 1 Tentative Agenda / July 22 (Wed.) Venue: 3F, Bldg. A, CTBC Financial Park 08:00-08:30 Registration BioBusiness Asia 2015 08:30-09:00 Opening Remarks / Minister P. H. Chiang, Ministry of Health & Welfare 09:00-09:40 09:40-10:20 10:20-10:50 Coffee Break 10:50-11:20 10:50-11:20 Session I : Vision & Opportunities on Precision Medicine Moderator: Johnsee Lee, Honorary Chairman of Taiwan Bio Industry Organization Vision toward a Better Future Healthcare Patrick Soon-Shiong, Founder & CEO, NantHealth / Chair Professor, UCLA The Precision Medicine Initiatives: Impacts & Opportunities Yun Yen, President of Taipei Medical University, Ex. Associate Director, City of Hope Medical Center Molecular Medicine & Companion Diagnostics Paul Herrling, Head of Cooperate Research, Novartis Clinical Sequencing for a More Effective Healthcare Radoje Drmanac, Founder & Chief Scientific Officer, Complete Genomics 11:50-12:30 Panel Discussion 12:30-13:50 BioTaiwan 2015 Luncheon 14:00-14:40 14:40-15:10 15:10-15:40 15:40-16:00 Coffee Break Session II : Biotech Investment Strategy Global Healthcare & Biotech Industry Development David Flores, Co-Funder, President & CEO, BioCentury Biotech Investment Opportunities in Asia Pacific Frank Kung, Managing Partner,Vivo Capital Investment Landscape in medical Technologies Yue-Teh Jang, General Manager and Director, Medeon Biodesign Inc. Session II 16:00-16:30 International Collaboraiton in Biotech Investment Ballroom A Ballroom A Ballroom B 16:30-17:00 Accelerating Biotech Growth by NDF Investment 17:00-18:00 Panel Discussion 16:00-18:00 Company Presentation Ballroom C Patrick Soon-Shiong Founder & CEO, NantHealth Chair Professor, UCLA Yun Yen President, Taipei Medical University Paul Herrling Head of Cooperate Research, Novartis Radoje Drmanac Founder & Chief Scientific Officer, Complete Genomics Andrew H.-J. Wang Distinguished Research Fellow, Academia Sinica; Co-Director, NRPB, Taiwan David Flores Co-Founder, President & CEO, BioCentury Ronald E. Law Vice President, New Frontier Science, Takeda Ajay Gautam Exec. Dir & Head, Asia & Emerging Markets, AstraZeneca Johnsee Lee Honorary Chairman, Taiwan Bio Industry Organization William L. Strauss Partner, Finnegan

BioBusiness Asia Conference 2015 Day 2 Tentative Agenda / July 23 (Thur.) Venue: 3F, Bldg. A, CTBC Financial Park Session III : Open Innovation & Partnering with Pharma Organized by: NRPB (National Research Program for Biopharmaceuticals) Ballroom A Moderator: Andrew H. J. Wang, Distinguished Research Fellow, Academia Sinica; Co-Director, NRPB, Taiwan 08:00-08:30 Registration 08:30-09:00 Opening Remarks / Andrew H.-J. Wang, Distinguished Research Fellow, Academia Sinica; Co-Director, NRPB, Taiwan 09:00-09:30 Open Innovation through Collaborative Partnerships Ajay Gautam, Exec. Dir & Head, Collaborations, Asia & Emerging Markets, AstraZeneca 09:30-10:00 Partnering from Big Pharma s Perspective / Ronald E. Law, VP, New Frontier Science, Takeda 10:00-10:20 Coffee Break 10:20-10:50 Early-stage Collaborations / Reginald Seeto, Vice President, Head of Partnering and Strategy, MedImmune 10:50-11:20 Maximizing the Value of Partnership / Mingde Xia, Senior Director, J&J Innovation, Asia-Pasific 11:20-12:30 Panel Discussion - How Can We Apply These Lessons to the Asian Market? 12:30-13:50 BioTaiwan 2015 Luncheon Session IV : IP Value Creation & International Collaboration Ballroom A 14:00-14:10 Opening Remarks / Wenji Chen, Director, World-Wide Business Development (WWBD), GSK 14:10-14:40 Co-development & Licensing / Branimir Brankov, Exec. Dir., Business Development, Emerging Markets, Merck 14:40-15:10 IP Value Creation & Deal Structuring Timothy R. Howe, President, Howe Ventures LLC, (former General Counsel and Head, M&A/Licensing Transactions, Sanofi) 15:10-15:30 Coffee Break 15:30-16:00 Key Considerations in Collaboration Agreements Susan H. Griffen / William L. Strauss, Partner, Finnegan 16:00-17:00 Panel Discussion - Unlocking Partnering Deals; Managing the Process & Cross Culture Issues Session V : Roadmap for a Successful Biologics Business Ballroom B Organized by: Medigen Vaccinology Corp 14:00-14:15 Opening Remarks 14:15-14:45 Understand Your Target Disease and Product Masato Tashiro (to be confirmed) Director, National Institute of Infectious Diseases, Tokyo, Japan Director, WHO Collaborating Centre for Reference and Research on Influenza and of WHO Essential Reference Laboratory of GISRS 14:45-15:15 Build the Right Manufacturing Facility Klaus Hermansen, Senior Technology Partner, NNE Pharmaplan (to be confirmed) 15:15-15:30 Coffee Break 15:30-16:00 Navigate the Regulatory Requirements Lee Chung Keel, Special Advisor to the Minister of Food and Drug Safety (Korea) 16:00-16:30 Topic D (TBD) 16:30-17:00 Panel Discussion 09:00-17:00 Company Presentation Ballroom C Timothy R. Howe President, Howe Ventures LLC Susan H. Griffen Partner, Finnegan Mingde Xia Senior Director, New Ventures, Johnson & Johnson Innovation, Asia-Pacific Masato Tashiro Director, National Institute of Infectious Diseases, Japan Klaus Hermansen Senior Technology Partner, NNE Pharmaplan Lee Chung Keel Special Advisor to the Minister of Food & Drug Safety, Korea

Join us for BioBusiness Asia Conference 2015 and OTHER BioTaiwan 2015 Events BioTaiwan 2015 Events at a Glance Come Meet your Taiwan & Asian Partners! Events 7/22(Wed.) 7/23 (Thur.) 7/24 (Fri.) 7/25 (Sat.) 7/26 (Sun.) BioBusiness Asia Conference CTBC Banquet Hall BioTaiwan Exhibition Exhibition Hall 4F Greater China Opportunities Exhibition Hall Conference R401 One-on-One Partnering Exhibition Hall 5F Concurrent Seminars Exhibition Hall 5F Workshops Exhibition Hall 5F Plenary Luncheon CTBC Banquet Hall BioTaiwan Banquet CTBC Banquet Hall Exhibition Hall / TWTC Nangang Exhibition Hall (No.1, Jingmao 2nd Rd., Nangang Dist., Taipei) CTBC Banquet Hall / China Trust Financial Park Building A, 3F (No.168, Jingmao 2nd Rd., Nangang Dist., Taipei) Why Taiwan? Global Rankings: Investment Risk #3 (BERI) Entrepreneurship #7, #1 Asia (GEDI) Global Competitiveness #13 (IMD) One-on-One Partnering BioTaiwan Conf. on Greater China Higher Education #12 (WEF) Innovation Capability #10 (WEF) Knowledge Based Economy #13, #1 Asia (World Bank) Scientific American Biotech Global Ratings Overall Competitiveness #17 BioBusiness Asia Seminars & Workshops Enterprise Support #6 Intensity #9 Foundation #12 Market Cap #3 (after US, Australia) Network with key stakeholders from Taiwan, China, Asia and all over the world Exhibit your unique products, technologies, services and bioclusters Uncover Taiwan and Asian biotech and pharmaceutical innovations Capture Asian and Greater China biotech market opportunities through Taiwan Explore R&D, product, service and business partnerships

Registration Package To attend BioBusiness Asia Conference, please register for package A or B. Program Packages A B C D E (Sat.) BioTaiwan Exhibition (7/23-7/26) BioBusiness Asia Conference (7/22-7/23) Greater China Opportunities Conference (7/24) One-on-One Partnering (7/23-7/24) Seminars & Workshops (7/23-7/25) Plenary Luncheon (7/22-7/23) BioTaiwan Banquet (7/22) Registration Fee USD 375 300 150 150 120 TWD 11,000 8,000 4,000 4,000 3,000 Early Bird (Before June 5th) USD 325 225 120 120 100 TWD 9,000 6,000 3,000 3,000 2,000 For registration please visit: www.bio-taiwan.com Optional Programs Program Company Presentation BioCruise Content Presenting your Company / Product / Service / Duration: 15 mins Date: 7/22 (Wed.) & 7/23 (Thur.) Location: Ballroom C, 3F Bldg. A, CTBC Financial Park Enjoy a relaxing networking opportunity with dinner, wine, live entertainment and beautiful night city view on Tamsui River BioCruise Location: Guandu Wharf (Great River Queen) Time: 7/23 (Thur.) 18:30-21:00 pm Dress Code: Smart Casual * shuttle bus pickup 17:15 from Exhibition Hall For registration please visit: www.bio-taiwan.com

BioBusiness Asia Conference 2015 Preliminary Program at a glance Time July 22 (Wed.) July 23 (Thur.) 08:00-08:30 Registration Registration 08:30-09:00 Opening Remarks Opening Remarks - NRPB 09:00-12:30 Session I Vision & Opportunities on Precision Medicine Session III Open Innovation & Partnering with Pharma Company Presentation 12:30-13:50 BioTaiwan Luncheon BioTaiwan Luncheon 14:00-15:50 16:00-18:00 Session II Biotech Investment Strategy Biotech Investment Strategy Company Presentation Session IV IP Value Creation & International Collaboration (14:00-17:00) Session V Roadmap for a Successful Biologics Business (14:00-17:00) Company Presentation 18:30-21:00 BioTaiwan Banquet Bio Cruise (17:15-21:00) Medigen